Summary
Tuesday, October 4, 2022: COVID-19 Test Results: 9 New Cases, Seven Hospitalized; Additional COVID-19 Updates
COVID-19 Test Results: 9 New Cases, Seven Hospitalized; Additional COVID-19 Updates
Special Note: Joint Information Center (JIC) releases, as they relate to COVID-19 results, will transition to twice-weekly updates as opposed to daily. Additional JIC releases throughout the week will be issued on an as-needed basis. To view the most up-to-date COVID-19 information, including weekday surveillance summary reports, visit http://dphss.guam.gov/covid-19/.
COVID-19 Test Results: 9 New Cases Reported
Today, the Department of Public Health and Social Services (DPHSS) reported 9 new cases of COVID-19 from 324 specimens collected September 28, 2022. To date, there have been a total of 58,600 officially reported cases, 401 deaths, 153 cases in active isolation, and 58,046 not in active isolation.
Two Hospitalized for COVID-19
CENSUS as of 4 p.m. | GMH | GRMC | USNH | TOTAL |
COVID-19 Admission | 1 | 6 | 0 | 7 |
Pediatric Admissions | 1 | – | – | 1 |
ICU | 0 | 0 | 0 | 0 |
Ventilator | 0 | 0 | 0 | 0 |
Bivalent Boosters Available at DPHSS Vaccination Clinics: On September 2, 2022, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommended the use of new bivalent formulations of Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines as a booster dose. A single booster dose of bivalent Pfizer-BioNTech COVID-19 Vaccine (for individuals age 12 years and older) or bivalent Moderna COVID-19 Vaccine (for individuals age 18 years and older) may be given at least 2 months after completion of a monovalent primary series or any prior monovalent booster dose of COVID-19 vaccine. This new booster recommendation replaces all prior booster recommendations only for people 12 years and older. At this time, there is no change to the monovalent vaccine schedules for children age 6 months through 11 years. Children age 5 through 11 years who have received a Pfizer-BioNTech primary series should continue to receive one monovalent booster dose.
- People must first complete at least a primary series with the original monovalent vaccine before receiving a single bivalent booster at least 2 months later.
- People may receive either brand of bivalent vaccine that is age-appropriate; there is no preference and no need to match the brand of the primary series.
- This recommendation is for a one-time booster. ACIP does not anticipate recommendations for frequent (e.g., every few months) booster doses of bivalent vaccine.
- COVID-19 vaccines may be co-administered with all other routinely recommended vaccines, including influenza vaccine.
The updated boosters are available at the DPHSS vaccination clinics at NRCHC, SRCHC, and our extended outreach vaccination events.
Novavax COVID-19 Vaccine Available at Northern Region Community Health Center: On August 9, DPHSS received 100 doses of the Novavax COVID-19 vaccine. The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for the Novavax vaccine on July 13. According to the CDC, the Novavax vaccine is a two-dose adjuvanted vaccine that is administered intramuscularly in deltoid muscle in adults 18 years of age or older. The Novavax vaccine is a two-dose primary series with three to eight weeks between dose one and dose two. Currently, the Novavax vaccine is not authorized for any booster dose. Additionally, individuals who complete their primary series with two doses of Novavax vaccine are not eligible for a booster dose at this time. The Novavax vaccine will be available at the DPHSS Northern Region Community Health Center in Dededo, while supplies last.
DPHSS mAb Treatment Center Open at Paseo Stadium: Bebtelovimab, a monoclonal antibody (mAb) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) is available at the DPHSS mAb treatment center at the Paseo Stadium in Hagåtña from 9 a.m. to 4 p.m., and closes for lunch from 12 p.m. to 1 p.m., Monday through Saturday. To schedule treatment at the DPHSS mAb treatment center, patients must call 671-998-4527 or 671-998-4547, have a current, laboratory-confirmed COVID–19 infection and a referral from a prescribing physician. For more information about Bebtelovimab and other mAb treatment options on Guam, visit dphss.guam.gov/mab or dial 311 from a local number and select option 1 on weekdays from 8 a.m. to 9 p.m. and on weekends and holidays from 8 a.m. to 5 p.m.
FREE COVID-19 COMMUNITY TESTING Fill out a COVID-19 Testing Patient Assessment Form ahead of time, available at dphss.guam.gov/covid-19-testing. During lightning and inclement weather, the drive-through sites may close. Residents are advised to visit our indoor test site in Tumon. | |
Tuesday, Thursday, and Saturday 8 a.m. – 11 a.m. | Old Carnival Grounds, Tiyan, Barrigada NO SYMPTOMS NEEDED TO TEST FOR COVID-19 Four adults per vehicle. Bring a photo ID. Travel-related testing will not be offered. |
Tuesday & Thursday 9 a.m. – 12 p.m. | DPHSS Southern Region Community Health Center (SRCHC), Inalåhan By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Travel-related testing not offered. Call (671) 828-7604/5/7518. |
Monday – Saturday 9 a.m. by appointment | DPHSS Northern Region Community Health Center (NRCHC), Dededo By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Call (671) 635-7525/6 to schedule an appointment. |
Monday – Saturday 9 a.m. – 12 p.m. 2 p.m. – 4 p.m. | Plaza Shopping Center – Dusit Beach Resort Guam, Tumon Bring a photo ID. |
Fill out a COVID-19 Testing Patient Assessment Form ahead of time, available at dphss.guam.gov/covid-19-testing.
FREE COVID-19 VACCINATION CLINICS MONOVALENT & BIVALENT BOOSTERS AVAILABLE – Pfizer-BioNTech, Moderna, Johnson & Johnson, Novavax* | |
Monday – Thursday BY APPOINTMENT ONLY Saturday: 9 a.m. – 12 p.m. Last vaccine will be administered 30 minutes before closing. | DPHSS Northern Region Community Health Center (NRCHC), Dededo To schedule an appointment for COVID-19 vaccination at NRCHC, residents must call 671-635-7400 or 671-635-4410. Curbside vaccination available for people with disabilities. *Novavax COVD-19 vaccine available only at NRCHC, while supplies last |
Monday – Friday BY APPOINTMENT ONLY | DPHSS Southern Region Community Health Center (SRCHC), Inalåhan To schedule an appointment for COVID-19 vaccination at SRCHC, call (671) 828-7604/5 or 828-8518. |
MONOVALENT & BIVALENT BOOSTERS AVAILABLE – Pfizer-BioNTech, Moderna, Johnson & Johnson, Novavax*
COVID-19 Vaccines for Children 6 Months and Older Available at DPHSS CHCs: The Moderna and the Pfizer-BioNTech COVID-19 Vaccines are authorized for use in children from six months of age and older. In most children, the Moderna COVID-19 vaccine for children ages six months through five years will be a two-dose primary series with four to eight weeks between dose one and dose two. In most children, the Pfizer-BioNTech COVID-19 vaccine for children ages six months through four years will be a three-dose primary series three to eight weeks between dose one and dose two, and at least eight weeks between dose two and dose three. Requirements for minors to receive the Moderna or Pfizer-BioNTech COVID-19 Vaccine at DPHSS vaccination clinics and outreach events:
- Parent/legal guardian must provide minor’s birth certificate
- Parent/legal guardian must have a government-issued photo identification
- Minor must be accompanied by a parent or legal guardian
- Guardians must present legal guardianship or power-of-attorney documents
Incentives Offered for COVID-19 Vaccination Series Completion and Boosters: A program administered by the government of Guam is providing incentives to individuals 12 years of age and older who maintain their COVID-19 vaccinations who are completing their last dose in primary series; OR receiving Monovalent Booster OR Bivalent Booster. Eligible residents will be offered an incentive (alcohol and tobacco items excluded) while supplies last. Gift certificates will only be offered at vaccination clinics at NRCHC, SRCHC, and senior citizen outreach clinics, while supplies last.
Guam COVID-19 Vaccination Update: As of September 21, 2022, 140,108 eligible residents (6 months and older) are fully vaccinated. This total includes 14,055 residents 12 – 17 years old. 9,077 residents 5 – 11 years old received their first dose of a two-dose series. 7,447 residents 5 – 11 years old have completed their two-dose series. 249 residents 6 months – 4 years old have received their first dose of a two-dose series. 70,667 eligible residents have received their first booster shots. 12,706 eligible residents have received their second booster shots.
GUAM’S COVID-19 COMMUNITY RISK LEVEL – As of September 23, 2022
Weekly Metrics Used to Determine the COVID-19 Community Level:
COVID-19 Community Level | LOW |
Case Rate per 100,000 Population | 67.7 Cases |
New COVID-19 Admissions per 100,000 Population | 7.2 Admissions |
% Staffed inpatient beds in use by patients with confirmed COVID-19 | 6.3% |
According to the U.S. Centers for Disease Control and Prevention (CDC), actions to take during all community risk levels are as follows:
Stay up to date on vaccination, including recommended booster doses.
Maintain ventilation improvements.
Avoid contact with people who have suspected or confirmed COVID-19.
Follow recommendations for isolation if you have suspected or confirmed COVID-19.
Follow the recommendations for what to do if you are exposed to someone with COVID-19.
If you are at high risk of getting very sick, talk with a healthcare provider about additional prevention actions.
Follow DPHSS Guidance Memo 2021-16 Rev. 4 for isolation and quarantine, including getting tested if you are exposed to COVID-19 or have symptoms of COVID-19
Determining COVID-19 Community Levels – Based on CDC Calculations:
New Cases1 (per 100,000 population in the last 7 days) | Indicator | Low | Medium | High |
---|---|---|---|---|
<200 cases | New COVID-19 admissions per 100,000 population (7-day total)2 | <10.0 | 10.0-19.9 | ≥20.0 |
Percent of staffed inpatient beds in use by COVID-19 patients (7-day average)3 | <10.0% | 10.0-14.9% | ≥15.0% | |
≥200 cases | New COVID-19 admissions per 100,000 population (7-day total) | NA | <10.0 | ≥10.0 |
Percent of staffed inpatient beds in use by COVID-19 patients (7-day average) | NA | <10.0% | ≥10.0% |
The COVID-19 Community Level is determined by the higher of the new admissions and inpatient beds metrics, based on the current level of new cases per 100,000 population in the past 7 days.
1Number of new cases in the county in the past 7 days divided by the population in the county (or other administrative level) multiplied by 100,000.
2Total number of new admissions of patients with confirmed COVID-19 in the past 7 days divided by the total population in the Health Service Area, multiplied by 100,000.
3Percentage of staffed inpatient beds in use by patients with confirmed COVID-19 within the entire Health Service Area (7-day average).
Recent Comments